Anders L. Carlson

4.8k total citations · 1 hit paper
71 papers, 1.2k citations indexed

About

Anders L. Carlson is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Anders L. Carlson has authored 71 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Endocrinology, Diabetes and Metabolism, 23 papers in Surgery and 15 papers in Genetics. Recurrent topics in Anders L. Carlson's work include Diabetes Management and Research (48 papers), Diabetes Treatment and Management (24 papers) and Pancreatic function and diabetes (21 papers). Anders L. Carlson is often cited by papers focused on Diabetes Management and Research (48 papers), Diabetes Treatment and Management (24 papers) and Pancreatic function and diabetes (21 papers). Anders L. Carlson collaborates with scholars based in United States, Belgium and United Kingdom. Anders L. Carlson's co-authors include Richard M. Bergenstal, Mary L. Johnson, Roy W. Beck, David Rodbard, Peiyao Cheng, Craig Kollman, Deborah M. Mullen, Amy Criego, Behrokh Khoshnevis and Thomas W. Martens and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Diabetes Care.

In The Last Decade

Anders L. Carlson

60 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Relationships Between Time in Range, Hyperglycemia Metrics, and HbA1c

2019 324 citations Roy W. Beck, Richard M. Bergenstal et al. Journal of Diabetes Science and Technology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anders L. Carlson United States	19	950	508	478	88	65	71	1.2k
Kanu Chatterjee United States	9	142 0.1×	35 0.1×	140 0.3×	25 0.3×	16 0.2×	12	437
Jennifer Sambrook United Kingdom	8	47 0.0×	39 0.1×	34 0.1×	8 0.1×	44 0.7×	11	390
Anand Vaz India	11	54 0.1×	538 1.1×	54 0.1×		24 0.4×	35	1.0k
Francisco Arredondo Spain	9	113 0.1×	166 0.3×	33 0.1×		69 1.1×	32	758
Serap Semiz Türkiye	12	152 0.2×	42 0.1×	55 0.1×		71 1.1×	35	455
Ruwan Fernando United Kingdom	16	20 0.0×	219 0.4×	10 0.0×	263 3.0×	25 0.4×	70	915
Yuki Kanno Japan	13	37 0.0×	142 0.3×	38 0.1×	1 0.0×	45 0.7×	33	528
Mark Harper United Kingdom	10	34 0.0×	118 0.2×	15 0.0×	5 0.1×	153 2.4×	19	504
W. Marsh United Kingdom	9	65 0.1×	176 0.3×	26 0.1×		19 0.3×	16	342

Countries citing papers authored by Anders L. Carlson

Since Specialization

Citations

This map shows the geographic impact of Anders L. Carlson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders L. Carlson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders L. Carlson more than expected).

Fields of papers citing papers by Anders L. Carlson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anders L. Carlson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders L. Carlson. The network helps show where Anders L. Carlson may publish in the future.

Co-authorship network of co-authors of Anders L. Carlson

This figure shows the co-authorship network connecting the top 25 collaborators of Anders L. Carlson. A scholar is included among the top collaborators of Anders L. Carlson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anders L. Carlson. Anders L. Carlson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Carlson, Anders L., Roy W. Beck, Zoey Li, et al.. (2025). Continuous Glucose Monitoring-Measured Glucose Levels During Oral Glucose Tolerance Testing in Pregnancy. Diabetes Technology & Therapeutics. 27(6). 439–448. 2 indexed citations

Bhargava, Anuj, Richard M. Bergenstal, Mark Warren, et al.. (2025). Safety and Effectiveness of MiniMed ^TM 780G Advanced Hybrid Closed-Loop Insulin Intensification in Adults with Insulin-Requiring Type 2 Diabetes. Diabetes Technology & Therapeutics. 27(5). 366–375. 3 indexed citations

Beck, Roy W., et al.. (2024). 63-OR: Continuous Glucose Monitoring Prediction of Gestational Diabetes Mellitus and Adverse Pregnancy Outcomes. Diabetes. 73(Supplement_1).

Carlson, Anders L., et al.. (2024). 265-OR: Understanding Patterns of GLP-1/GLP-1 RA Use among Individuals with Type 1 Diabetes—A T1D Exchange (T1DX) Online Registry Analysis. Diabetes. 73(Supplement_1). 1 indexed citations

Li, Zoey, Roy W. Beck, Celeste Durnwald, et al.. (2024). Continuous Glucose Monitoring Prediction of Gestational Diabetes Mellitus and Perinatal Complications. Diabetes Technology & Therapeutics. 26(11). 787–796. 3 indexed citations

Durnwald, Celeste, Roy W. Beck, Zoey Li, et al.. (2024). Continuous Glucose Monitoring–Derived Differences in Pregnancies With and Without Adverse Perinatal Outcomes. Obstetrics and Gynecology. 144(5). 684–696. 4 indexed citations

Carlson, Anders L., Timothy E. Graham, Halis Kaan Aktürk, et al.. (2024). Control-IQ Technology Use in Individuals With High Insulin Requirements: Results From the Multicenter Higher-IQ Trial. Journal of Diabetes Science and Technology. 18(6). 1288–1292. 3 indexed citations

Davis, Georgia M., Anne L. Peters, Bruce W. Bode, et al.. (2024). Glycaemic outcomes in adults with type 2 diabetes over 34 weeks with the Omnipod® 5 Automated Insulin Delivery System. Diabetes Obesity and Metabolism. 27(1). 143–154. 4 indexed citations

Durnwald, Celeste, Roy W. Beck, Zoey Li, et al.. (2024). Continuous Glucose Monitoring Profiles in Pregnancies With and Without Gestational Diabetes Mellitus. Diabetes Care. 47(8). 1333–1341. 28 indexed citations

10.

Davis, Georgia M., Anne L. Peters, Bruce W. Bode, et al.. (2023). Safety and Efficacy of the Omnipod 5 Automated Insulin Delivery System in Adults With Type 2 Diabetes: From Injections to Hybrid Closed-Loop Therapy. Diabetes Care. 46(4). 742–750. 37 indexed citations

11.

Mizokami‐Stout, Kara, Ryan Bailey, Lynn Ang, et al.. (2022). Symptomatic diabetic autonomic neuropathy in type 1 diabetes (T1D): Findings from the T1D exchange. Journal of Diabetes and its Complications. 36(5). 108148–108148. 8 indexed citations

12.

Forlenza, Gregory P., Anders L. Carlson, Rodolfo J. Galindo, et al.. (2022). Real-World Evidence Supporting Tandem Control-IQ Hybrid Closed-Loop Success in the Medicare and Medicaid Type 1 and Type 2 Diabetes Populations. Diabetes Technology & Therapeutics. 24(11). 814–823. 35 indexed citations

13.

Bode, Bruce W., Anders L. Carlson, Rong Liu, et al.. (2021). Ultrarapid Lispro Demonstrates Similar Time in Target Range to Lispro with a Hybrid Closed-Loop System. Diabetes Technology & Therapeutics. 23(12). 828–836. 26 indexed citations

14.

Aleppo, Grazia, Christopher G. Parkin, Anders L. Carlson, et al.. (2021). Lost in Translation: A Disconnect Between the Science and Medicare Coverage Criteria for Continuous Subcutaneous Insulin Infusion. Diabetes Technology & Therapeutics. 23(10). 715–725. 8 indexed citations

15.

Galindo, Rodolfo J., Christopher G. Parkin, Grazia Aleppo, et al.. (2021). What's Wrong with This Picture? A Critical Review of Current Centers for Medicare & Medicaid Services Coverage Criteria for Continuous Glucose Monitoring. Diabetes Technology & Therapeutics. 23(9). 652–660. 26 indexed citations

16.

Svensson, Ann‐Marie, Laura Young, Anders L. Carlson, et al.. (2021). Renal Complications and Duration of Diabetes: An International Comparison in Persons with Type 1 Diabetes. Diabetes Therapy. 12(12). 3093–3105. 8 indexed citations

17.

Zylla, Dylan M., et al.. (2019). Impact of diabetes and hyperglycemia on health care utilization, infection risk, and survival in patients with cancer receiving glucocorticoids with chemotherapy. Journal of Diabetes and its Complications. 33(4). 335–339. 22 indexed citations

18.

Buse, John B., Anders L. Carlson, Mitsuhisa Komatsu, et al.. (2018). Efficacy and Safety of Faster Aspart Compared with Insulin Aspart Both with Insulin Degludec in Adults with T1D. Diabetes. 67(Supplement_1). 1 indexed citations

19.

Carlson, Anders L., et al.. (2014). State of the Art Methodology to Assess Energy Facade Retrofits (EFR). 4 indexed citations

20.

Chase‐Dunn, Christopher, et al.. (2010). Middlemen and Marcher States in Central Asia and East/West Empire Synchrony. Social Evolution & History. 9(1). 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact